Koers Herborium Group, Inc. Other OTC
Aandelen
HBRM
US42703A2087
Biotechnologie & Medisch Onderzoek
Omzet 2010 | 262K 246K | Omzet 2011 | 234K 220K | Marktkapitalisatie | 210K 197K |
---|---|---|---|---|---|
Nettowinst (verlies) 2010 | - 0 | Nettowinst (verlies) 2011 | - 0 | EV/omzet 2010 | 10,7 x |
Nettoschuld 2010 | 588K 551K | Nettoschuld 2011 | 621K 582K | EV/omzet 2011 | 3,55 x |
K/w-verhouding 2010 |
-4,35
x | K/w-verhouding 2011 |
-0,97
x | Werknemers | - |
Dividendrendement 2010 * |
-
| Dividendrendement 2011 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Agnes Olszewski
CEO | Chief Executive Officer | 67 | 04-06-02 |
John Donahue
AUD | Comptroller/Controller/Auditor | 74 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Agnes Olszewski
CEO | Chief Executive Officer | 67 | 04-06-02 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-3,46% | 102 mld. | |
+1,41% | 96,29 mld. | |
+2,13% | 22,18 mld. | |
-15,84% | 21,2 mld. | |
-9,21% | 18,31 mld. | |
-39,98% | 17,38 mld. | |
-14,65% | 16,36 mld. | |
+4,39% | 13,97 mld. | |
+31,35% | 12,17 mld. |